Muhammad Asim

Muhammad Asim

Auto-generated profile, based on publicly available information

Muhammad Asim

Division of Nephrology, Department of Internal Medicine, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2019 in World Journal of Nephrology
Verified
Journal Article
Open access
MAMuhammad Asim
Muhammad Asim
MAMohamad M Alkadi
Mohamad M Alkadi
HAHania Asim
Hania Asim
AGAdil Ghaffar
Adil Ghaffar
Dehydration and volume depletion: How to handle the misconceptions

1 April 2022 in International Journal of Nephrology and Renovascular Disease
Verified
Journal Article
Open access
PDF file
MAMuhammad Asim
Muhammad Asim
MAMohammed Akhtar
Mohammed Akhtar
Anti-glomerular basement membrane (anti-GBM) disease is a rare but serious autoimmune disease, which is characterized by the development of pathogenic antibodies to type IV collagen antigens in the glomerular and alveolar basement membranes. This results in rapidly progressive glomerulonephritis (GN), alveolar hemorrhage, or both. A variety of environmental factors can trigger the disease in genetically predisposed patients. Temporal associations with influenza, SARS-CoV-2 infection, and COVID-19 vaccination have been described although there is insufficient evidence to suggest causality. Anti-GBM disease accounts for approximately 20% of the cases of rapidly progressive GN cases secondary to crescentic GN, but is an uncommon cause of end-stage kidney disease. Early diagnosis by detection of circulating antibodies, increased awareness of atypical as well as complex clinical variants of the disease, and combined therapy with immunosuppression and plasma exchange has improved the prognosis of patients with this potentially fatal disease. Progress has been hampered by the rarity of anti-GBM disease, but new agents and therapeutic regimens are emerging.

29 November 2020 in World Journal of Nephrology
Verified
Journal Article
Open access
MAMuhammad Asim
Muhammad Asim
MAMohamad Alkadi
Mohamad Alkadi
AHAbdullah Hamad
Abdullah Hamad
MOMuftah Othman
Muftah Othman
EAEssa Abuhelaiqa
Essa Abuhelaiqa
HAHassan Al-Malki
Hassan Al-Malki
Restructuring nephrology services to combat COVID-19 pandemic: Report from a Middle Eastern country

4 February 2021 in American Journal of Case Reports
Verified
Journal Article
Closed access
MAMuhammad Asim
Muhammad Asim
FAFarooq Ahmad
Farooq Ahmad
MAMohammed Akhtar
Mohammed Akhtar
Florid Interstitial Hemorrhages: A Novel Feature of Amoxicillin-Clavulanate-Induced Acute Tubulointerstitial Nephritis - Article abstract #928989

11 June 2021 in Transplantation Proceedings
Verified
Journal Article
Open access
MAMohamad Alkadi
Mohamad Alkadi
HAHassan Al-Malki
Hassan Al-Malki
MAMuhammad Asim
Muhammad Asim
OFOmar M. Fituri
Omar M. Fituri
AHAhmed F. Hamdi
Ahmed F. Hamdi
EAEssa Abuhelaiqa
Essa Abuhelaiqa
Introduction: : This study aimed to evaluate the incidence of coronavirus disease 2019 (COVID-19) infection on kidney transplant, mortality, and risk factors associated with infection acquisition and severe illness in kidney transplant recipients with COVID-19. Methods: : Among 693 kidney transplant recipients who reported to our center, 249 were tested for COVID-19 by throat and nasal swab reverse transcription polymerase chain reaction. Of these, 43 and 206 recipients tested positive and negative, respectively. Among the 43 positive recipients, nine were treated within an isolation facility, 25 were admitted to the hospital, and nine were admitted to the intensive care unit (ICU). Risk factors associated with positive results and ICU admission were evaluated. Results: : COVID-19 was found in 6% of transplant recipients. Asian ethnicity (P=0.003), history of hypertensive nephropathy (P=0.01), AB blood group (P=0.04), and higher tacrolimus trough levels (P=0.007) were more frequent in the COVID-19 positive than in the COVID-19 negative group. ICU admission was more frequent in recipients presenting with fever, shortness of breath, and acute allograft dysfunction. Renal replacement therapy was required in 3 (7%) of 43 recipients, and mortality was reported in 1 (2.3%) recipient. Acute allograft dysfunction was an independent risk factor for severe COVID-19 (odds ratio 93.7 [95% confidence interval 2.37-3710.94], P=0.02). Conclusion: : Higher tacrolimus targets may be associated with COVID-19 development. Acute kidney injury during the COVID-19 course may be a sign of severe disease. Prognostication of COVID-19 severity in kidney transplant recipients is crucial for early recognition of critical illness and may ensure early intervention.

31 December 2015 in Qatar Medical Journal
Verified
Journal Article
Open access
ZAZakira Afghan
Zakira Afghan
AHAbid Hussain
Abid Hussain
MAMuhammad Asim
Muhammad Asim
SCShah Ct
Shah Ct
RJRizqallah Jj
Rizqallah Jj
FJFontes J
Fontes J
Primary headache disorders account for the majority of the cases of headache. Nevertheless, the primary objective of a physician, when encountered with a patient with headache is to rule out a secondary cause the headache. This entails a search for specific associated red-flag symptoms or signs that may indicate a serious condition, as well as a heightened suspicion of and evaluation for a don't miss diagnosis. We present a case of a high-school student whose first manifestation of systemic lupus erythematosus (SLE) was a headache due to cerebral venous and sinus thrombosis, initially misdiagnosed as tension-headache and ‘ophthalmoplegic migraine’ (now known as ‘recurrent painful ophthalmoplegic neuropathy’). The patient made a complete neurological and radiological recovery after systemic anticoagulation and treatment of SLE. An analysis of the clinical errors and cognitive biases leading to delayed referral to hospital is presented. We highlight the fact that adherence to the fundamental principles of clinical medicine and enhancement of cognitive awareness is required to reduce diagnostic errors.